Highly effective second-line anti-Helicobacter pylori therapy in patients with previously failed metronidazole-based therapy

Scandinavian Journal of Gastroenterology

Volumn 32, Issue 12, 1997, Pages 1209-1214

  Lerang, F ^a   Moum, B ^b   Haug, J B ^b   Berge, T ^b   Tolas P ^b   Sandvei, P K ^b   Torp, R ^b   Tonnesen T ^b  

^a Østfold Hospital   (Norway)

^b NONE

Author keywords

Antimicrobial resistance; Clarithromycin; Helicobacter pylori; Metronidazole; Second line therapy; Triple therapy

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; OXYTETRACYCLINE; TETRACYCLINE DERIVATIVE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0031467306     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529709028149     Document Type: Article

References (33)

1. Tefera S, Berstad A, Bang CJ, Nysæther G, Hatlebakk JG, Olafsson S, et al. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain). Am J Gastroenterol 1996;91:935-41.
2. Bell GD, Bate CM, Axon ATR, Tildesley G, Kerr GD, Green JRB, et al. Addition of metronidazole to omeprazole/amoxycillin dual therapy increases the rate of Helicobacter pylori eradication: a double-blind, randomized trial. Aliment Pharmacol Ther 1995;9:513-20.
3. de Boer WA, Tytgat GNJ. How to treat Helicobacter pylori infection-should treatment strategies be based on testing bacterial susceptibility? A personal viewpoint [review]. Eur J Gastoenterol Hepatol 1996;8:709-16.
4. Bell GD, Powell KU, Burridge SM, Bowdwn AF, Atoyebi W, Bolton GH, et al. Rapid eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 1995;9:41-6.
5. Peitz U, Nusch A, Tillenburg B, Stolte M, Borsch G, Labenz J. High cure rate of H. pylori infection by one-week therapy with omeprazole, metronidazole and clarithromycin despite a negative impact by metronidazole resistance. Gut 1996;39 Suppl 2:A5.
6. Harris AW, Pryce DI, Gabe SM, Karim QN, Walker MM, Langworthy H, et al. Lansoprazole, clarithromycin and metronidazole for seven days in Helicobacter pylori infection. Aliment Pharmacol Ther 1996;10:1005-8.
7. Lerang F, Mourn B, Haug JB, Tolås P, Breder O, Aubert E, et al. Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance? Am J Gastroenterol 1997;92:248-53.
8. Borody TJ, Andrews P, Brandl S, Devine M. Relevance of invitro metronidazole resistance to H. pylori eradication and eradication failure. Gastroenterology 1993;104:A44.
9. Borody TJ, Andrews P, Fracchia G, Brandl S, Shortis NP, Bae H. Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori. Gut 1995;37:477-81.
10. Al-Assi MT, Ramirez FC, Lew GM, Genta RM, Graham DY. Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection. Am J Gastroenterol 1994;89:1203-5.
11. Laine L, Estrada R, Trujillo M, Fukanaga K, Neil G. Randomized comparison of differing periods of twice-a-day triple therapy for the eradication of Helicobacter pylori. Aliment Pharmacol Ther 1996;10:1029-33.
12. Lerang F, Moum B, Ragnhildstveit E, Haug JB, Hauge T, Tolås P, et al. A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: a prospective randomized 1-yr follow-up study. Am J Gastroenterol 1997;92:653-8.
13. van der Hust RWM, Keller JJ, Rauws EAJ, Tytgat GNJ. Treatment of Helicobacter pylori infection: a review of the world literature. Helicobacter 1996;1:6-19.
14. Borody TJ, Andrews P, Shortis NP. Features of patients who fail all attempts at Helicobacter pylori (HP) eradication. Am J Gastroenterol 1994;89:1365.
15. Noach LA, Bertola MA, Schwarts MP, Rauws EAJ, Tytgat GNJ. Treatment of Helicobacter pylori infection: an evaluation of various therapeutic trials. Eur J Gastroenterol Hepatol 1994;6: 585-91.
16. Cayla R, Zerbib F, Talbi P, Megraud F, Lamouliatte H. Pre and post-treatment clarithromycin resistance of Helicobacter pylori strains: a key factor of treatment failure. Gut 1995;37 Suppl 1:A55.
17. Borody TJ, Shortis NP, Chongnan J, Reyes E, O'Shea JE. Eradication failure (EF) after H. pylori treatment - further therapies. Gastroenterology 1996;110:A67.
18. Reilly TG, Ayres RCS, Poxon V, Walt RP. Helicobacter pylori eradication in a clinical setting: success rates and the effect on the quality of life in peptic ulcer. Aliment Pharmacol Ther 1995;9:483-90.
19. Seppala K, Sipponen P, Nuutinen H, Farkkila M, Anisimova S, Kosunen TU. Intent to treat metronidazole resistant H. pylori infection to 100% of cure. Therapy with quadruple therapy and its modification. Gastroenterology 1995;108:A216.
20. Moshkowitz M, Konikoff FM, Peled Y, Brill S, Hallak A, Tiomny E, et al. One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: differing efficacy in previously treated and untreated patients. Aliment Pharmacol Ther 1996;10:1015-9.
21. Lind T, Veldhuyzen van Zanten S, Unge P, Spiller R, Bayerdorffer E, O'Morain C, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: The MACH 1 study. Helicobacter 1996;1:138-44.
22. Yousfi MM, El-Zimaity HMT, Genta RM, Graham DY. One-week triple therapy with omeprazole, amoxycillin and clarithromycin for treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 1996;10:617-21.
23. Labenz J, Stolte M, Peitz U, Tillenburg B, Becker T, Borsch G. One-week triple therapy with omeprazole, amoxycillin and either clarithromycin or metronidazole for cure of Helicobacter pylori infection. Aliment Pharmacol Ther 1996;10:207-10.
24. Peitz U, Tillenburg B, Becker T, Stolte M, Borsch G, Labenz J. Highly effective well tolerated one-week therapy with omeprazole, clarithromycin and amoxicillin for Helicobacter pylori (HP) infection. Gastroenterology 1996;110:A 226.
25. Lamouliatte H, Cayla R, Zerbib F, Talbi P, Megraud F, de Mascarel A. Triple therapy with PPI-amoxicillin-clarithromycin for H. pylori eradication: the optimal regimen in 1996. Gastroenterology 1996;110:A171.
26. Delchier JC, Elamine I, Goldfain D, Chaussade S, Barthelemy P, Idstrøm JP. Omeprazole-amoxycillin versus omeprazole-amoxycillin-clarithromycin in the eradication of Helicobacter pylori. Aliment Pharmacol Ther 1996;10:263-8.
27. Thijs JC, van Zwet AA, Moolenaar W, Ooms JAJ, de Kortes H, Runhaar EA. Short report: clarithromycin, an alternative to metronidazole in triple therapy of Helicobacter pylori infection. Aliment Pharmacol Ther 1994;8:131-4.
28. Graham DY, de Boer WA, Tytgat GNJ. Choosing the best anti-Helicobacter pylori therapy: effect of antimicrobial resistance. Am J Gastroenterol 1996;91:1072-6.
29. Walt RP. Metronidazole-resistant H. pylori - of questionable clinical importance. Lancet 1996;348:489-90.
30. Yousfi MM, El-Zimaity HMT, Cole RA, Genta RM, Graham DY. Metronidazole, ranitidine and clarithromycin combination tor treatment of Helicobacter pylori infection (modified Bazzoli's triple therapy). Aliment Pharmacol Ther 1996;10: 119-22.
31. Moayyedi P, Tompkins DS, Mapstone N, Axon ATR. Relevance of antibiotic sensitivities in predicting failure of omeprazole, clarithromycin and tinidazole to eradicate Helicobacter pylori. Gut 1996;38 Suppl 1:A38.
32. Hulten K, Engslrand L. Acquired and persistent macrolide resistance in patients treated with clarithromycin. Gut 1996;39 Suppl 2:A8.
33. Debets-Ossenkopp YJ, Sparrius M, Kusters JG, Kolkman CMJ. Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori [abstract]. Gut 1996;39 Suppl 2:A8.